Building a bionic pancreas to improve the lives of people with type 1 diabetes
At Beta Bionics, Inc., we are developing a bionic pancreas system called the iLet™, a revolutionary fully integrated and wearable bionic pancreas medical device platform that automatically and autonomously manages blood sugar levels in people with insulin-dependent type 1 diabetes (T1D) 24/7. The iLet promises to dramatically improve clinical outcomes and profoundly reduce the burden and cost of diabetes care.
We are driven to build a technology that will automatically manage our children’s diabetes, day and night, and keep them safe from the far-reaching harms, the immediate dangers, the emotional burden, and the fear that type 1 diabetes carries with it every day of their lives. That technology will provide a bridge that spans the divide between where we are today and the biological cure of tomorrow – a cure that has been ever present in our dreams, and ever elusive from our lives.
- 6 outpatient human clinical trials already completed.
- Backed by almost 10 years of clinical data.